Ljubljana/team

From 2007.igem.org

(Difference between revisions)
Line 1: Line 1:
<html>
<html>
<head>
<head>
-
<title>Ljubljana team</title>
+
<title>Company Name</title>
-
 
+
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
 +
<link href="http://rokgaber.3host.biz/stylenew_zadaj.css" rel="stylesheet" type="text/css" />
</head>
</head>
<body>
<body>
 +
 +
<div id="container">
 +
  <div id="intro">
 +
    <div id="pageHeader">
 +
 +
 +
 +
 +
   
 +
    </div>
 +
   
 +
  </div>
 +
 +
 +
 +
 +
 +
 +
  <div id="supportingText">
 +
 +
 +
 +
 +
<div id="products">
 +
      <h3><span>iGEM 2007 Team Slovenia</span></h3>
 +
      <p class="p1"><span>
<img src="https://static.igem.org/mediawiki/2007/7/71/SLOteamOctober_small.jpg"  
<img src="https://static.igem.org/mediawiki/2007/7/71/SLOteamOctober_small.jpg"  
Line 14: Line 41:
<area shape="rect"  
<area shape="rect"  
coords="25,31,119,214"  
coords="25,31,119,214"  
-
alt="Roman"
+
alt="Roman Jerala"
href="roman.htm">
href="roman.htm">
<area shape="rect"  
<area shape="rect"  
coords="217,146,264,334"  
coords="217,146,264,334"  
-
alt="Rok"
+
alt="Rok Gaber"
href="rok.htm">
href="rok.htm">
<area shape="rect"  
<area shape="rect"  
coords="329,132,383,330"  
coords="329,132,383,330"  
-
alt="Andrej"
+
alt="Andrej Ondracka"
href="andrej.htm">
href="andrej.htm">
<area shape="rect"  
<area shape="rect"  
coords="445,140,499,332"  
coords="445,140,499,332"  
-
alt="Pero"
+
alt="Peter Cimermancic"
href="pero.htm">
href="pero.htm">
<area shape="rect"  
<area shape="rect"  
coords="544,52,623,376"  
coords="544,52,623,376"  
-
alt="MarkoD"
+
alt="Marko Dolinar"
href="markod.htm">
href="markod.htm">
<area shape="rect"  
<area shape="rect"  
coords="139,48,180,127"  
coords="139,48,180,127"  
-
alt="Gabi"
+
alt="Gabriela Panter"
href="gabi.htm">
href="gabi.htm">
<area shape="rect"  
<area shape="rect"  
coords="182,79,218,196"  
coords="182,79,218,196"  
-
alt="Mojca"
+
alt="Mojca Bencina"
href="mojca.htm">
href="mojca.htm">
<area shape="rect"  
<area shape="rect"  
coords="220,50,257,120"  
coords="220,50,257,120"  
-
alt="Mateja"
+
alt="Mateja Mancek Keber"
href="mateja.htm">
href="mateja.htm">
<area shape="rect"  
<area shape="rect"  
coords="264,71,301,193"  
coords="264,71,301,193"  
-
alt="Sasa"
+
alt="Sasa Jereb"
href="sasa.htm">
href="sasa.htm">
<area shape="rect"  
<area shape="rect"  
coords="317,64,369,129"  
coords="317,64,369,129"  
-
alt="Karolina"
+
alt="Karolina Ivicak"
href="karolina.htm">
href="karolina.htm">
<area shape="rect"  
<area shape="rect"  
coords="390,45,419,185"  
coords="390,45,419,185"  
-
alt="MarkoB"
+
alt="Marko Bitenc"
href="markob.htm">
href="markob.htm">
<area shape="rect"  
<area shape="rect"  
coords="427,58,463,132"  
coords="427,58,463,132"  
-
alt="Anja"
+
alt="Anja Korencic"
href="anja.htm">
href="anja.htm">
<area shape="rect"  
<area shape="rect"  
coords="471,59,518,138"  
coords="471,59,518,138"  
-
alt="Katja"
+
alt="Katja Kolar"
href="katja.htm">
href="katja.htm">
 +
</span></p><br>
-
</body>
 
 +
 +
     
 +
      <h3><span>Header</span></h3>
 +
      <p class="p1">One of the first AIDS therapeutics were nucleotide or nucleoside analogues (NRTI – nucleoside-analogue reverse transcriptase inhibitors) – pseudosubstrates, that are during reverse transcription integrated into viral DNA instead of nucleosides and thus block the transcription. These drugs were superseded by non-nucleoside inhibitors (NNRTI) that could inhibit reverse transcriptase by binding into the alosteric site of the enzyme. The third type of drugs is a family of HIV protease inhibitors. In most cases specific inhibitors are very similar to protease substrates - the only difference is that because they cannot be cut, they block the active site by remaining bound into it.</p>
 +
 +
 +
   
 +
    </div>
 +
 +
 +
 +
   
 +
 +
 +
   
 +
   
 +
    <div id="footer">______________________________________<br />
 +
     
 +
|<a href="https://2007.igem.org/Ljubljana">Home</a>|
 +
<a href="https://2007.igem.org/Ljubljana/HIVbacground">HIV-1 Infection Background</a>
 +
</div>
 +
 +
 +
  </div>
 +
  <div id="linkList">
 +
    <div id="linkList2">
 +
      <div id="lmenu">
 +
        <h3 class="menu"><span><a class="two" href="https://2007.igem.org/Ljubljana/AIDSplague">AIDS - Today's Plague</a></span></h3>
 +
        <ul>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/HIVbacground">HIV-1 Infection Background</a>&nbsp; </li>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/Currenttreatment">Current Disease Treatment</a>&nbsp; </li>
 +
        </ul>
 +
      </div>
 +
      <div id="llinks">
 +
        <h3 class="links"><span><a class="two" href="https://2007.igem.org/Ljubljana/Strategy">Strategy</a></span></h3>
 +
        <ul>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/implementation">Implementation</a>&nbsp; </li>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/model">Model</a>&nbsp; </li>
 +
        </ul>
 +
      </div>
 +
      <div id="lresources">
 +
        <h3 class="resources"><span><a class="two" href="https://2007.igem.org/Ljubljana/results">Results</a></span></h3>
 +
        <ul>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/subsystems">Subsystems Testing</a>&nbsp; </li>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/finalsystem">Performance of the Final Functional Systems</a>&nbsp; </li>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/biobricks">BioBricks</a>&nbsp; </li>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/methods">Methods</a>&nbsp; </li>
 +
        </ul>
 +
      </div>
 +
 +
      <div id="lresults">
 +
        <h3 class="results"><span><a class="two" href="https://2007.igem.org/Ljubljana/summary">Summary</a></span></h3>
 +
        <ul>
 +
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/achievements">Achievements</a>&nbsp; </li>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/prospects">Prospects</a>&nbsp; </li>
 +
 +
         
 +
        </ul>
 +
      </div>
 +
 +
<div id="ldiscussion">
 +
        <h3 class="discussion"><span><a class="two" href="https://2007.igem.org/Ljubljana/team">Team</a></span></h3>
 +
        <ul>
 +
         
 +
<br><br>
 +
<li><a class="one" href="https://2007.igem.org/Ljubljana/glossary">Terms & References</a>&nbsp; </li>
 +
<li><a class="one" href="https://2007.igem.org/Ljubljana/acknowledgements">Acknowledgements</a>&nbsp; </li>
 +
        </ul>
 +
      </div>
 +
<center>
 +
<a href="http://www3.clustrmaps.com/counter/maps.php?url=https://2007.igem.org/Ljubljana" id="clustrMapsLink"><img src="http://www3.clustrmaps.com/counter/index2.php?url=https://2007.igem.org/Ljubljana" style="border:0px;" alt="Locations of visitors to this page" title="Locations of visitors to this page" id="clustrMapsImg" onError="this.onError=null; this.src='http://www2.clustrmaps.com/images/clustrmaps-back-soon.jpg'; document.getElementById('clustrMapsLink').href='http://www2.clustrmaps.com'" />
 +
</a>
 +
</center>
 +
 +
    </div>
 +
 +
  </div>
 +
 +
</div>
 +
 +
 +
</body>
</html>
</html>

Revision as of 21:32, 25 October 2007

Company Name

iGEM 2007 Team Slovenia

Roman Jerala Rok Gaber Andrej Ondracka Peter Cimermancic Marko Dolinar Gabriela Panter Mojca Bencina Mateja Mancek Keber Sasa Jereb Karolina Ivicak Marko Bitenc Anja Korencic Katja Kolar


Header

One of the first AIDS therapeutics were nucleotide or nucleoside analogues (NRTI – nucleoside-analogue reverse transcriptase inhibitors) – pseudosubstrates, that are during reverse transcription integrated into viral DNA instead of nucleosides and thus block the transcription. These drugs were superseded by non-nucleoside inhibitors (NNRTI) that could inhibit reverse transcriptase by binding into the alosteric site of the enzyme. The third type of drugs is a family of HIV protease inhibitors. In most cases specific inhibitors are very similar to protease substrates - the only difference is that because they cannot be cut, they block the active site by remaining bound into it.